Search For "dr reddy"
NSE lists ADRs at NSE IFSC in GIFT City
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], December 9 (ANI): NSE International Exchange, a wholly-owned subsidiary of the National Stock Exchange (NSE) of India Ltd, has become the first in GIFT City to list American Depository Receipts (ADRs) with Dr Reddy's Laboratories being the first Indian corporate
Read More
Clinical trials of Sputnik V vaccine begins in India
Updated : 5 years, 8 months ago IST
New Delhi [India], December 1 (ANI): Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia commenced in India on Tuesday.
Read More
PM Modi appreciates scientists' efforts to come out with vaccine solution
Updated : 5 years, 8 months ago IST
New Delhi [India], November 30 (ANI): Prime Minister Narendra Modi on Monday appreciated the efforts by scientists in Gennova Biopharmaceuticals Ltd, Biological E Ltd and Dr. Reddys Laboratories Ltd to come out with a vaccine solution to tackle COVID-19.
Read More
Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Russia, Ukr
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], November 29 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. today announced that it has entered into a definitive agreement with Dr. Reddy's Laboratories Ltd. to divest - subject to completion of certain precedent actions and closing activities - its brand Mo
Read More
Drugs regulator refuses application of Dr Reddy's Lab for marketing author
Updated : 5 years, 9 months ago IST
New Delhi [India], November 2 (ANI): The top drug regulator has refused Dr Reddy's Laboratories' application, for full marketing authorization of anti-viral drug Remdesivir, for treatment of COVID-19 patients in India.
Read More
Dr Reddy's Laboratories isolates all its data centre services following cy
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], October 23 (ANI): The pharmaceutical company Dr Reddy's Laboratories Ltd has isolated all its data centres following a cyber attack on Thursday.
Read More
Expert panel recommends DCGI to permit Dr Reddy's Lab to conduct phase 2,3
Updated : 5 years, 9 months ago IST
New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of Russian COVID-19 vaccine candidate, Sputnik V, in India, government officials s
Read More
Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clini
Updated : 5 years, 9 months ago IST
New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
Read More
Equity indices flat amid lacklustre trading, private lenders lose
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], October 13 (ANI): Equity benchmark indices were flat during early hours on Tuesday tracking Asian peers which witnessed downside in early deals.
Read More
DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for
Updated : 5 years, 9 months ago IST
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
Read More
Dr Reddy's joins Science Based Targets initiative (SBTi), sets 2030 GHG em
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], October 5 (ANI): Dr Reddy's Laboratories has joined the Science Based Targets initiative's (SBTi) business ambition for 1.5 degrees celsius, becoming the first Indian and third Asian pharmaceutical company to minimise environmental impact.
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 5 years, 10 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More